Care, Management, and Symptom Relief

Because there is currently no approved disease-modifying therapy or cure for CLN13 (Kufs disease type B), the primary focus of medical care is to manage symptoms, maximize independence, and ensure comfort ^[1][2]. While other types of Batten disease, such as CLN2, have specific enzyme-replacement therapies, these do not work for the CTSF mutation found in CLN13 ^[3][4].

Building Your Multidisciplinary Care Team

Managing a complex neurodegenerative condition requires a team of specialists working together. Because the disease affects the brain, body, and behavior, your care team should include:

• Neurologist / Movement Disorder Specialist: To monitor disease progression and prescribe medications for tremors, stiffness (parkinsonism), or seizures ^[5][6].
• Physical (PT) and Occupational (OT) Therapists: To help with mobility, provide fall-prevention strategies, and recommend adaptive equipment (like walkers or specialized chairs) ^[7].
• Speech-Language Pathologist (SLP): To assist with communication challenges and, more importantly, to perform swallowing evaluations to ensure eating remains safe ^[8].
• Palliative Care Team: These specialists focus on “quality of life” at any stage of a serious illness. They can help manage difficult symptoms like pain or sleep issues and guide the family through complex future decisions ^[5][7].

Symptom-Directed Management

While the disease itself cannot be stopped, many of its symptoms can be managed with targeted interventions:

• Seizures and Myoclonus: If seizures or sudden muscle jerks (myoclonus) occur, they are typically treated with antiseizure medications. These must be tailored to the individual, as some medications can actually worsen certain types of myoclonus ^[5][1].
• Mobility and Safety: As balance and coordination decline, the goal shifts to preventing falls ^[9]. This may involve home modifications (like grab bars) and a transition from walking independently to using a wheelchair ^[7][10].
• Nutrition and Swallowing: Difficulty swallowing (dysphagia) is common in the later stages ^[8]. An SLP should perform an individualized instrumental assessment (such as a modified barium swallow) to guide safe eating. General strategies like “thickened liquids” without assessment can sometimes worsen dehydration or increase residue risk. In advanced cases, families may need to discuss the benefits and risks of a feeding tube (gastrostomy) to support nutrition and medication delivery, though it is important to understand that a feeding tube does not reliably prevent aspiration ^[11][12].

Urgent Red Flags

While CLN13 is a slowly progressive disease, certain symptoms require immediate medical attention to prevent serious complications. Seek emergency care if you notice:

1. Prolonged or New Seizures: Any seizure lasting longer than five minutes (status epilepticus) or a sudden cluster of multiple seizures in a short period ^[13][14]. Utilize your prescribed seizure action plan and rescue medication as directed (first aid: time the seizure, protect from injury, do not restrain the person or put anything in their mouth).
2. Sudden Respiratory Distress: Severe shortness of breath, rapid breathing, cyanosis (a bluish tint to the lips), or an inability to clear the airway ^[15][12].
3. Significant Falls: Any fall that results in a head injury, severe pain, or an inability to move a limb ^[10].

Prompt Clinical Review: Some symptoms warrant prompt medical review but not necessarily emergency transport. For example, frequent coughing, choking, or a “wet” gurgling voice during or after meals should prompt a swallowing evaluation ^[11].

Rapid Decline: While the disease is progressive, a sudden loss of ability (over hours or days rather than months) may indicate a separate, treatable problem like an infection, dehydration, medication effects, constipation, or stroke, rather than the disease itself ^[11][16].